Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Akebia's Vafseo wins FDA approval 2 years after rejection
Aekbia earned a second chance for its oral chronic kidney disease anemia med after appealing the agency's 2022 complete response letter.
Zoey Becker
Mar 28, 2024 9:25am
GLP-1s still unavailable in lower-income countries: MSF
Mar 28, 2024 8:00am
Sponsored
BioDesign: Accelerating the Momentum of Bioconjugate Therapeutics
Mar 25, 2024 8:00am
WuXi Biologics stays the course with positive 2024 outlook
Mar 27, 2024 1:44pm
Sponsored
The biopharma “brain drain”: Finding talent to fuel innovation
Jan 26, 2024 8:00am
AZ plans separate drug supply chains for US and China, CEO says
Mar 27, 2024 12:27pm